全球腦血氧儀市場（按產品類型、應用、技術、區域範圍）預測至 2025 年

腦體血氧儀的市場規模及預測

2024 年全球腦體血氧儀市場規模為 2.6267 億美元，預計到 2032 年將達到 4.4457 億美元，2026 年至 2032 年的複合年成長率為 7.50%。

腦血氧儀是醫療設備，可提供有關腦部氧合和血流的寶貴資訊。

它主要用於在手術、加護治療和神經系統檢查期間監測和管理患者，以發現缺氧和腦缺血等潛在問題。

腦體血氧儀的未來包括非侵入性監測技術的進步、與更廣泛的健康監測系統的整合以及在各種臨床環境中的擴展使用，所有這些都受到持續的技術創新和對準確大腦健康監測日益成長的需求的推動。

全球腦體血氧儀市場動態

影響全球腦體血氧儀市場的關鍵市場動態是：

關鍵市場促進因素

神經系統疾病盛行率不斷上升：中風和腦損傷等神經系統疾病盛行率不斷上升，推動了對腦血氧儀的需求。 2024年6月，Medtronic擴大了其腦監測解決方案的產品範圍，以滿足日益成長的醫療保健需求。

監測設備的技術發展：血氧測定技術的進步，例如改進的感測器和即時數據分析，將提高腦體血氧儀的準確性和功能性。例如，2024年7月，Nonin Medical推出了一款新型先進腦血氧儀，其訊號處理能力已提升。

更加重視病人安全和監測。在手術和重症加護期間，病人安全和持續監測受到更多重視。 2024年4月，美國食品藥物管理局（FDA）核准了一種新型腦血氧儀，標誌著監管機構對先進監測技術的支持日益增強。

醫療設施的擴張和投資：醫療基礎設施的擴張和對先進診斷工具的投資正在推動市場成長。飛利浦醫療保健於2024年3月宣布了一項重大投資，以擴展其腦血氧儀產品線，以滿足醫院和外科中心日益成長的需求。

主要挑戰

先進設備高成本：先進的腦血氧儀價格高昂，可能成為其普及的重大障礙，尤其是在資源匱乏的醫療環境中。此類設備的高昂成本往往會限制最尖端科技的普及。

準確度和校準差異：由於校準和感測器技術的差異，腦血氧儀的準確度差異可能是一個問題。在多種設備和不同患者條件下保持一致可靠的測量結果仍然是首要任務。

與現有系統整合的複雜性：將腦體血氧儀整合到現有的醫療監測系統中可能比較困難，並且需要額外的基礎設施改造。對於醫療機構而言，這個整合過程既困難又耗時。

認知和培訓有限：醫療保健專業人員通常缺乏如何正確使用腦血氧儀的認知或培訓，這可能導致使用效率低下和低估該設備在患者照護中的潛在益處。

主要趨勢

先進監測系統的整合：將腦血氧儀與其他先進監測系統（例如麻醉和重症加護設備）相結合的趨勢日益成長。這種整合增強了全面的病患監測和即時數據分析，從而改善臨床療效。

穿戴式和行動裝置的發展：穿戴式和可攜式腦血氧儀可以在傳統醫院環境之外進行持續、方便的監測，並且越來越受歡迎。

非侵入性技術的進步：技術進步旨在改進非侵入性測量技術，從而獲得更準確、更可靠的腦血氧飽和度數據。最近的進展包括先進的感測器技術和改進的訊號處理演算法。

在各種臨床環境中的應用日益廣泛：腦體血氧儀在神經外科以外的臨床環境中的應用日益廣泛，例如循環系統和產科。這些設備在各個醫療領域的應用表明，它們在監測各種患者狀況下的腦氧水平方面的效用日益增強。

目錄

第1章 引言

• 市場定義
• 市場區隔
• 調查方法

第2章執行摘要

• 主要發現
• 市場概覽
• 市場亮點

第3章市場概述

• 市場規模和成長潛力
• 市場趨勢
• 市場促進因素
• 市場限制
• 市場機會
• 波特五力分析

第4章腦體血氧儀市場（依產品類型）

• 非侵入性腦體血氧儀
• 侵入式腦體血氧儀

第5章腦血氧儀市場（依應用）

• 神經重症重症加護
• 麻醉學
• 新生兒護理
• 循環系統
• 運動醫學

第6章腦血氧儀市場（依技術）

• 近紅外線光譜（NIRS）
• 光聲光譜（PAS）
• 漫波相關光譜（DCS）

第7章區域分析

• 北美洲
• 美國
• 加拿大
• 墨西哥
• 歐洲
• 英國
• 德國
• 法國
• 義大利
• 亞太地區
• 中國
• 日本
• 印度
• 澳洲
• 拉丁美洲
• 巴西
• 阿根廷
• 智利
• 中東和非洲
• 南非
• 沙烏地阿拉伯
• 阿拉伯聯合大公國

第8章市場動態

• 市場促進因素
• 市場限制
• 市場機會
• COVID-19 市場影響

第9章 競爭態勢

• 主要企業
• 市場佔有率分析

第10章 公司簡介

• Masimo
• Medtronic
• Edwards Lifesciences
• ISS Inc.
• Nonin Medical, Inc.
• Koninklijke Philips NV
• Mespere LifeSciences
• GE Healthcare

第11章 市場展望與機會

• 新興技術
• 未來市場趨勢
• 投資機會

第12章 附錄

• 簡稱列表
• 來源和參考文獻

Cerebral Somatic Oximeters Market Size And Forecast

Global Cerebral Somatic Oximeters Market size was valued at USD 262.67 Million in 2024 and is projected to reach USD 444.57 Million by 2032, growing at a CAGR of 7.50% from 2026 to 2032.

Cerebral somatic oximeters are medical devices that measure oxygen levels in brain tissues, providing valuable information about cerebral oxygenation and blood flow.

They are primarily used to monitor and manage patients during surgeries, intensive care, and neurological examinations in order to detect potential problems such as hypoxia or brain ischemia.

The future of cerebral somatic oximeters includes advancements in non-invasive monitoring technologies, integration with broader health monitoring systems, and expanded use in a variety of clinical settings, all driven by ongoing innovation and the growing demand for precise cerebral health monitoring.

Global Cerebral Somatic Oximeters Market Dynamics

The key market dynamics that are shaping the global cerebral somatic oximeters market include:

Key Market Drivers:

Increasing Prevalence of Neurological Disorders: The growing prevalence of neurological disorders, such as stroke and brain injuries, is driving up demand for cerebral somatic oximeters. Medtronic expanded its range of cerebral monitoring solutions in June 2024 to meet the growing healthcare demand.

Technological Developments in Monitoring Devices: Oximetry technology advancements, such as improved sensors and real-time data analysis, improve the accuracy and functionality of cerebral somatic oximeters. For example, in July 2024, Nonin Medical unveiled a new advanced cerebral oximeter with improved signal processing capabilities.

Growing Emphasis on Patient Safety and Monitoring: There is a greater emphasis on patient safety and continuous monitoring during surgeries and critical care. In April 2024, the US Food and Drug Administration (FDA) approved a new cerebral oximeter device, demonstrating increased regulatory support for advanced monitoring technologies.

Expansion of Healthcare Facilities and Investments: The expansion of healthcare infrastructure, as well as investments in advanced diagnostic tools, are driving market growth. Philips Healthcare announced a significant investment in March 2024 to expand its cerebral oximetry product line in response to increasing demand in hospitals and surgical centers.

Key Challenges:

High Cost of Advanced Devices: The high cost of advanced cerebral somatic oximeters can be a significant barrier to adoption, particularly in low-resource healthcare settings. Access to cutting-edge technologies is frequently limited due to the high cost of such equipment.

Variability in Accuracy and Calibration: Variability in cerebral oximeter accuracy can be problematic due to differences in calibration and sensor technology. Maintaining consistent and reliable readings across multiple devices and patient conditions remains a top priority.

Complexity of Integration with Existing Systems: Integrating cerebral somatic oximeters with current medical monitoring systems can be difficult and may necessitate additional infrastructure changes. This integration process can be difficult and time-consuming for healthcare facilities.

Limited Awareness and Training: Healthcare professionals frequently lack awareness and training on how to use cerebral somatic oximeters properly. This can result in inefficient use and underestimation of the device's potential benefits in patient care.

Key Trends:

Integration of Advanced Monitoring Systems: There is an increasing trend of combining cerebral somatic oximeters with other advanced monitoring systems, such as anesthesia and critical care equipment. This integration enhances comprehensive patient monitoring and real-time data analysis, resulting in better clinical outcomes.

Development of Wearable and Portable Devices: Wearable and portable cerebral oximeters are becoming increasingly popular, allowing for continuous and convenient monitoring outside of traditional hospital settings.

Advancements in Non-invasive Technologies: Technological advancements are aimed at improving non-invasive measurement techniques, resulting in more accurate and reliable cerebral oxygenation data. Recent advancements include advanced sensor technologies and improved signal processing algorithms.

Growing Use in Various Clinical Settings: Cerebral somatic oximeters are increasingly used in clinical settings other than neurosurgery, such as cardiology and obstetrics. The use of these devices in various medical fields demonstrates their growing utility in monitoring cerebral oxygen levels in a variety of patient conditions.

Global Cerebral Somatic Oximeters Market Regional Analysis

Here is a more detailed regional analysis of the global cerebral somatic oximeters market:

North America:

North America is emerging as the dominant force in the cerebral somatic oximeters market, owing to advanced healthcare infrastructure, high adoption rates of cutting-edge medical technologies, and significant R&D investments. The United States, in particular, dominates this market due to its large number of well-equipped hospitals, strict patient safety regulations, and high prevalence of cardiovascular and neurological disorders.

The region's dominance is reinforced by the presence of major market players such as Medtronic, Edwards Lifesciences, and Nonin Medical, which are constantly innovating and improving their cerebral oximetry technology. Furthermore, the growing emphasis on reducing perioperative complications and improving patient outcomes in surgical and critical care settings has accelerated the adoption of these devices in North American healthcare facilities.

In February 2024, Medtronic unveiled its next-generation cerebral somatic oximeter which includes artificial intelligence to provide more accurate tissue oxygenation monitoring during complex surgeries. This launch is expected to strengthen Medtronic's market position and accelerate adoption rates in North American hospitals. In April 2024, the United States Food and Drug Administration (FDA) issued new guidelines for the use of cerebral oximetry in pediatric cardiac surgeries, emphasizing the importance of continuous cerebral monitoring in high-risk procedures. This regulatory update is expected to increase demand for cerebral somatic oximeters in pediatric care units across the United States, thereby expanding the market in North America.

Asia Pacific:

The Asia Pacific region is projected to witness fastest growth in the cerebral somatic oximeters, owing to increased awareness of patient monitoring during surgeries, rising healthcare costs, and growing adoption of advanced medical technologies. Countries such as China, Japan, India, and South Korea are at the forefront of this expansion, with large populations and rapidly developing healthcare infrastructures driving significant demand for these devices. The region's emphasis on improving patient outcomes, particularly in critical care and surgical settings, has resulted in an increase in the use of cerebral oximeter technology. Furthermore, the rising prevalence of cardiovascular and neurological disorders among Asia's aging populations has increasing demand for these monitoring devices.

In March 2024, Masimo Corporation, a global leader in noninvasive monitoring technologies, announced that it would expand its manufacturing facilities in Malaysia to meet Asia Pacific's growing demand for cerebral oximeters. This move is expected to significantly boost the availability of these devices in the region. In January 2024, the Chinese National Health Commission announced a new five-year plan to improve perioperative patient safety, which includes significant investments in advanced monitoring technologies such as cerebral somatic oximeters. This initiative is expected to increase the adoption of these devices in Chinese hospitals, accelerating market growth in the Asia Pacific region.

Global Cerebral Somatic Oximeters Market: Segmentation Analysis

The Global Cerebral Somatic Oximeters Market is segmented on the basis of By Product Type, By Application, By Technology and Geography.

Global Cerebral Somatic Oximeters Market, By Product Type

• Non-invasive Cerebral Somatic Oximeters
• Invasive Cerebral Somatic Oximeters

Based on Product Type, the Global Cerebral Somatic Oximeters Market is segmented into Non-invasive Cerebral Somatic Oximeters and Invasive Cerebral Somatic Oximeters. Non-invasive cerebral somatic oximeters are popular due to their widespread use and preference for monitoring without the need for surgical procedures, resulting in ease of use and patient comfort. The invasive cerebral somatic oximeters segment is the fastest growing, driven by rising demand for precise and direct measurements in complex and high-risk medical procedures where accuracy is critical.

Global Cerebral Somatic Oximeters Market, By Application

• Neurocritical Care
• Anesthesiology
• Neonatal Care
• Cardiology
• Sports Medicine

Based on Application, the Global Cerebral Somatic Oximeters Market is segmented into Neurocritical Care, Anesthesiology, Neonatal Care, Cardiology, and Sports Medicine. The neurocritical care segment is dominant because it plays an important role in monitoring cerebral oxygenation in patients with severe neurological conditions and during complex surgeries. The neonatal care segment is expanding at the fastest rate, owing to increased awareness of the importance of monitoring cerebral oxygen levels in newborns and advances in neonatal care technology.

Global Cerebral Somatic Oximeters Market, By Technology

• Near-infrared spectroscopy (NIRS)
• Photoacoustic spectroscopy (PAS)
• Diffuse correlation spectroscopy (DCS)

Based on Technology, the Global Cerebral Somatic Oximeters Market is segmented into Near-infrared spectroscopy (NIRS), Photoacoustic spectroscopy (PAS), Diffuse correlation spectroscopy (DCS). Near-infrared spectroscopy (NIRS) is the dominant technology due to its long history of use in non-invasive monitoring of cerebral oxygenation and widespread adoption in clinical settings. Diffuse correlation spectroscopy (DCS) is the fastest-growing segment, thanks to its advanced capabilities for real-time measurements of cerebral blood flow and oxygenation, which has sparked increased interest and investment in this emerging technology.

Global Cerebral Somatic Oximeters Market, By Geography

• North America
• Europe
• Asia Pacific
• Rest of the World

Based on the Geography, the Global Cerebral Somatic Oximeters Market are classified into North America, Europe, Asia Pacific, and Rest of the World. North America is the dominant region due to its advanced healthcare infrastructure, widespread adoption of medical technologies, and the presence of major medical device manufacturers. Asia Pacific is the fastest-growing region, owing to increased investments in healthcare infrastructure, rising prevalence of neurological disorders, and rising demand for advanced monitoring solutions in emerging economies such as China and India.

Key Players

The "Global Cerebral Somatic Oximeters Market" study report will provide valuable insight with an emphasis on the global market. The major players in the market are Masimo, Medtronic, Edwards Lifesciences, ISS, Inc., Nonin Medical, Inc., Mespere LifeSciences, GE Healthcare.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with its product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

• Global Cerebral Somatic Oximeters Market: Recent Developments
• In April 2024, Philips Healthcare introduced a new line of cerebral somatic oximeters that incorporate cutting-edge technology for better patient monitoring and integration with existing healthcare systems.
• In May 2024, Nihon Kohden launched a portable cerebral oximeter with the goal of providing continuous monitoring in a variety of clinical settings, including emergency and neonatal care, while also improving mobility and ease of use.
• In March 2024, Nonin Medical introduced a new cerebral oximeter with upgraded sensor technology, promising improved accuracy and reliability in a variety of patient conditions, including critical and routine monitoring.

TABLE OF CONTENTS

1. Introduction

• Market Definition
• Market Segmentation
• Research Methodology

2. Executive Summary

• Key Findings
• Market Overview
• Market Highlights

3. Market Overview

• Market Size and Growth Potential
• Market Trends
• Market Drivers
• Market Restraints
• Market Opportunities
• Porter's Five Forces Analysis

4. Cerebral Somatic Oximeters Market, By Product Type

• Non-invasive Cerebral Somatic Oximeters
• Invasive Cerebral Somatic Oximeters

5 Crebral Somatic Oximeters Market, By Application

• Neurocritical Care
• Anesthesiology
• Neonatal Care
• Cardiology
• Sports Medicine

6 Cerebral Somatic Oximeters Market, By Technology

• Near-infrared spectroscopy (NIRS)
• Photoacoustic spectroscopy (PAS)
• Diffuse correlation spectroscopy (DCS)

7. Regional Analysis

• North America
• United States
• Canada
• Mexico
• Europe
• United Kingdom
• Germany
• France
• Italy
• Asia-Pacific
• China
• Japan
• India
• Australia
• Latin America
• Brazil
• Argentina
• Chile
• Middle East and Africa
• South Africa
• Saudi Arabia
• UAE

8. Market Dynamics

• Market Drivers
• Market Restraints
• Market Opportunities
• Impact of COVID-19 on the Market

9. Competitive Landscape

• Key Players
• Market Share Analysis

10. Company Profiles

• Masimo
• Medtronic
• Edwards Lifesciences
• ISS Inc.
• Nonin Medical, Inc.
• Koninklijke Philips N.V.
• Mespere LifeSciences
• GE Healthcare

11. Market Outlook and Opportunities

• Emerging Technologies
• Future Market Trends
• Investment Opportunities

12. Appendix

• List of Abbreviations
• Sources and References